298 related articles for article (PubMed ID: 19162497)
41. Does lowering cholesterol have an impact on the progression of aortic stenosis?
Greve AM; Wachtell K
Ther Adv Cardiovasc Dis; 2008 Aug; 2(4):277-86. PubMed ID: 19124427
[TBL] [Abstract][Full Text] [Related]
42. Atherosclerotic inflammation triggers osteogenic bone transformation in calcified and stenotic human aortic valves: still a matter of debate.
Anger T; Carson W; Weyand M; Daniel WG; Hoeher M; Garlichs CD
Exp Mol Pathol; 2009 Feb; 86(1):10-7. PubMed ID: 19084515
[TBL] [Abstract][Full Text] [Related]
43. [Pathogenesis of calcific aortic valve stenosis].
Kaden JJ
Herz; 2006 Oct; 31(7):620-8. PubMed ID: 17072774
[TBL] [Abstract][Full Text] [Related]
44. [Calcific and degenerative aortic stenosis--pathogenesis and new possibilities of treatment].
Podolec P; Kopeć G; Rubiś P; Kabłak-Ziembicka A; Rokita E; Tracz W
Przegl Lek; 2004; 61(6):604-8. PubMed ID: 15724645
[TBL] [Abstract][Full Text] [Related]
45. Targeted therapy to prevent progression of calcific aortic stenosis.
Rajamannan NM; Otto CM
Circulation; 2004 Sep; 110(10):1180-2. PubMed ID: 15353511
[No Abstract] [Full Text] [Related]
46. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.
Cowell SJ; Newby DE; Prescott RJ; Bloomfield P; Reid J; Northridge DB; Boon NA;
N Engl J Med; 2005 Jun; 352(23):2389-97. PubMed ID: 15944423
[TBL] [Abstract][Full Text] [Related]
47. Common pathogenic features of atherosclerosis and calcific aortic stenosis: role of transforming growth factor-beta.
Xu S; Liu AC; Gotlieb AI
Cardiovasc Pathol; 2010; 19(4):236-47. PubMed ID: 19942455
[TBL] [Abstract][Full Text] [Related]
48. COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification.
Vieceli Dalla Sega F; Fortini F; Cimaglia P; Marracino L; Tonet E; Antonucci A; Moscarelli M; Campo G; Rizzo P; Ferrari R
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255450
[TBL] [Abstract][Full Text] [Related]
49. Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis.
Tsimikas S
Circ Res; 2019 Feb; 124(3):405-415. PubMed ID: 30702993
[TBL] [Abstract][Full Text] [Related]
50. Can calcific aortic stenosis be prevented?
Conti CR
Clin Cardiol; 2002 May; 25(5):201-2. PubMed ID: 12018877
[No Abstract] [Full Text] [Related]
51. Histopathology of calcific aortic valve stenosis.
Somers P; Knaapen M; Mistiaen W
Acta Cardiol; 2006 Oct; 61(5):557-62. PubMed ID: 17117757
[TBL] [Abstract][Full Text] [Related]
52. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis.
Kaden JJ; Dempfle CE; Grobholz R; Fischer CS; Vocke DC; Kiliç R; Sarikoç A; Piñol R; Hagl S; Lang S; Brueckmann M; Borggrefe M
Cardiovasc Pathol; 2005; 14(2):80-7. PubMed ID: 15780799
[TBL] [Abstract][Full Text] [Related]
53. Statin therapy and aortic stenosis: a systematic review of the effects of statin therapy on aortic stenosis.
Loomba RS; Arora R
Am J Ther; 2010; 17(4):e110-4. PubMed ID: 19417587
[TBL] [Abstract][Full Text] [Related]
54. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation.
Passmore M; Nataatmadja M; Fung YL; Pearse B; Gabriel S; Tesar P; Fraser JF
Eur J Cardiothorac Surg; 2015 Sep; 48(3):e20-9. PubMed ID: 26273067
[TBL] [Abstract][Full Text] [Related]
55. The role of statins in aortic stenosis. Myth or reality?
Moura LM; Zamorano J; Peréz-Oteyza C; Rocha-Gonçlves F; Rajamannan NM
Rev Port Cardiol; 2007 Jan; 26(1):51-62. PubMed ID: 17427836
[TBL] [Abstract][Full Text] [Related]
56. Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis.
Donato M; Ferri N; Lupo MG; Faggin E; Rattazzi M
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158204
[TBL] [Abstract][Full Text] [Related]
57. Atherosclerosis, degenerative aortic stenosis and statins.
Novo G; Fazio G; Visconti C; Carità P; Maira E; Fattouch K; Novo S
Curr Drug Targets; 2011 Jan; 12(1):115-21. PubMed ID: 20863278
[TBL] [Abstract][Full Text] [Related]
58. Demographic characteristics of patients undergoing aortic valve replacement for stenosis: relation to valve morphology.
Davies MJ; Treasure T; Parker DJ
Heart; 1996 Feb; 75(2):174-8. PubMed ID: 8673757
[TBL] [Abstract][Full Text] [Related]
59. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
Kaden JJ; Vocke DC; Fischer CS; Grobholz R; Brueckmann M; Vahl CF; Hagl S; Haase KK; Dempfle CE; Borggrefe M
Z Kardiol; 2004 Feb; 93(2):124-30. PubMed ID: 14963678
[TBL] [Abstract][Full Text] [Related]
60. Calcific aortic stenosis: an update.
Rajamannan NM; Bonow RO; Rahimtoola SH
Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):254-62. PubMed ID: 17457349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
